AAAAAA
Results:
1-8
|
Results: 8
Authors:
FERNANDEZ P
MARIN F
ROLDAN V
LUJAN J
MARCO P
MARTINEZ JG
CALATAYUD R
Citation: P. Fernandez et al., TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS WITH MYOCARDIAL-INFARCTION, British Journal of Haematology, 102(1), 1998, pp. 132-132
Authors:
ROLDAN V
FERNANDEZ C
MARCO P
BERDU J
DEPAZ F
PASCUAL E
Citation: V. Roldan et al., SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS HAVE HIGH AMOUNTS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI), British Journal of Haematology, 102(1), 1998, pp. 134-135
Authors:
ROLDAN V
FERNANDEZ C
MARCO P
VERDU J
DEPAZ F
PASCUAL E
Citation: V. Roldan et al., ENDOTHELIAL DAMAGE MARKERS IN SYSTEMIC LUPUD ERYTHEMATOSUS PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 248-248
Authors:
FERNANDEZ P
MARIN F
LUJAN J
ROLDAN V
GARCIA MC
MARCO P
SOGORB F
Citation: P. Fernandez et al., INFARCTION AND FIBRINOLYSIS, 2 YEARS FOLLOW-UP, British Journal of Haematology, 102(1), 1998, pp. 258-258
Authors:
ROLDAN V
MARIN F
MARCO P
MARTINEZ JG
GARCIA MC
FERNANDEZ P
SOGORB F
Citation: V. Roldan et al., HYPOFIBRINOLYTICAL FUNCTION IN CHRONIC ATRIAL-FIBRILLATION - EFFECTS OF ANTICOAGULATION TREATMENT, British Journal of Haematology, 102(1), 1998, pp. 266-266
Authors:
FERNANDEZ C
ROLDAN V
MARCO P
VERDU J
BATLLE E
PASCUAL E
Citation: C. Fernandez et al., HIGH AMOUNTS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN LUPUS PATIENTS AND THE RELATIONSHIPS WITH LUPUS ACTIVITY AND DAMAGE, Arthritis and rheumatism, 41(9), 1998, pp. 1115-1115
Authors:
GARCIA MC
ROYO M
MARCO P
ROLDAN V
FERNANDEZ P
ESPANA F
Citation: Mc. Garcia et al., HEMOSTATIC CHANGES IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS DURING ALL-TRANS-RETINOIC ACID (ATRA) THERAPY, Thrombosis and haemostasis, 1997, pp. 512-512
Authors:
ROLDAN V
MARIN F
MARCO P
FERNANDEZ P
GARCIA MC
MARTINEZ JG
SOGORB F
Citation: V. Roldan et al., PATIENTS WITH CHRONIC ATRIAL-FIBRILLATION HAVE HIGH AMOUNTS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1), Thrombosis and haemostasis, 1997, pp. 618-618
Risultati:
1-8
|